Identification of a Novel <i>GOLGB1-RET</i> Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib

Shogen Boku, Takao Fujisawa, Shigenori Kadowaki, Hironaga Satake, Hisateru Yasui, Koushiro Ohtsubo, Yasushi Shimizu, Tomoyuki Otsuka, Bunya Kuze, Riu Yamashita, Taro Shibuki, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Milan Radovich, Susumu Okano

Open source

DOI: 10.1200/po-26-00237
Published: 2026-07
Container: JCO Precision Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-26-00237,
  title = {Identification of a Novel
                    <i>GOLGB1-RET</i>
                    Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib},
  author = {Shogen Boku and Takao Fujisawa and Shigenori Kadowaki and Hironaga Satake and Hisateru Yasui and Koushiro Ohtsubo and Yasushi Shimizu and Tomoyuki Otsuka and Bunya Kuze and Riu Yamashita and Taro Shibuki and Yoshiaki Nakamura and Hideaki Bando and Takayuki Yoshino and Milan Radovich and Susumu Okano},
  year = {2026},
  journal = {JCO Precision Oncology},
  doi = {10.1200/po-26-00237},
  url = {https://doi.org/10.1200/po-26-00237}
}

RIS

TY  - JOUR
TI  - Identification of a Novel
                    <i>GOLGB1-RET</i>
                    Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib
AU  - Shogen Boku
AU  - Takao Fujisawa
AU  - Shigenori Kadowaki
AU  - Hironaga Satake
AU  - Hisateru Yasui
AU  - Koushiro Ohtsubo
AU  - Yasushi Shimizu
AU  - Tomoyuki Otsuka
AU  - Bunya Kuze
AU  - Riu Yamashita
AU  - Taro Shibuki
AU  - Yoshiaki Nakamura
AU  - Hideaki Bando
AU  - Takayuki Yoshino
AU  - Milan Radovich
AU  - Susumu Okano
PY  - 2026
JO  - JCO Precision Oncology
DO  - 10.1200/po-26-00237
UR  - https://doi.org/10.1200/po-26-00237
ER  -

APA

Boku, S., Fujisawa, T., Kadowaki, S., Satake, H., Yasui, H., Ohtsubo, K., Shimizu, Y., Otsuka, T., Kuze, B., Yamashita, R., Shibuki, T., Nakamura, Y., Bando, H., Yoshino, T., Radovich, M., & Okano, S. (2026). Identification of a Novel <i>GOLGB1-RET</i> Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib. JCO Precision Oncology. https://doi.org/10.1200/po-26-00237

Source records

crossref · retrieved 2026-09-26T23:52:53.084Z